Graphic Packaging (GPK) Q4 2025 earnings review
Kitchen Sink Quarter: Margins Compress, 2026 Guidance Resets Lower
Graphic Packaging delivered a sobering Q4 report. While revenue was flat at $2.1B, profitability deteriorated significantly due to production curtailments and cost pressures. Adjusted EBITDA fell 23% YoY, compressing margins to 14.8%. The real shock is the 2026 guidance: management forecasts a ~17% drop in Adjusted EBITDA and a ~47% drop in Adjusted EPS at the midpoint compared to 2025. CEO Robbert Rietbroek initiated a 'comprehensive review' of operations and the portfolio, signaling a major strategic reset is underway.
🐂 Bull Case
The massive capital cycle is over. With the Waco facility substantially complete, CapEx will drop to ~$450M in 2026 (from $935M in 2025). This drives Adjusted Free Cash Flow guidance to $700-$800M, providing firepower for debt reduction.
The painful $130M EBITDA hit projected for 2026 related to inventory reduction suggests the company is ripping the band-aid off to right-size working capital, potentially setting up a cleaner 2027.
🐻 Bear Case
The 2026 outlook implies a stunning degradation in earnings power. Adjusted EPS is guided to $0.75-$1.15, down from $1.80 in 2025 and $2.49 in 2024. The operational leverage has reversed sharply.
Net Leverage Ratio climbed to 3.8x from 3.0x a year ago. With EBITDA falling in 2026, the company is more levered than preferred entering a period of operational uncertainty.
⚖️ Verdict: 🔴
Bearish. The 'kitchen sink' guidance for 2026 resets earnings expectations drastically lower. While the free cash flow story is intact due to lower CapEx, the deterioration in core profitability and the sudden need for a 'strategic review' indicate structural challenges.
Key Themes
Guidance Shock: 2026 Earnings Recession
Management guided 2026 Adjusted EBITDA to $1.05-$1.25B, significantly below the $1.395B delivered in 2025. They cite a $130M impact from inventory reduction and a $100M accrual for incentive compensation reset. This implies margins will likely remain compressed near Q4 levels rather than bouncing back to the 19% historical range.
Margin Compression
Decelerating. Adjusted EBITDA margin compressed 450 basis points YoY to 14.8% in Q4. This was driven by lower pricing (-1%), cost inflation, and 'negative Net Performance' from curtailing production. The efficiency story touted in prior years has temporarily broken.
Strategic Review Initiated
CEO Rietbroek announced a 'comprehensive review' of the organization structure, operations, footprint, and a 'selective review' of the portfolio. This language often precedes divestitures, plant closures (beyond those already announced), or major restructuring charges, adding near-term execution risk.
Waco Complete: CapEx Cliff Arrives
The massive Waco, Texas recycled paperboard facility is 'substantially complete' with $1.58B spent through 2025. This triggers a massive drop in CapEx to ~$450M in 2026 (down from $935M in 2025). This mechanical reduction is the sole driver of the expected Free Cash Flow recovery.
Innovation Sales Growth
A rare bright spot: Innovation Sales grew $56M in Q4 and $213M for the full year (~2.5% of sales). This proves the product portfolio (plastic replacement, etc.) still has traction even as the broader business faces cyclical headwinds.
Other KPIs
Deteriorating. Increased from 3.0x in 2024 to 3.8x in 2025. Net debt stands at $5.33B. With EBITDA expected to decline in 2026, deleveraging will rely entirely on debt paydown from free cash flow rather than EBITDA growth.
Stable. Flat vs $2,095M in 24Q4. Pricing declined 1% and volumes were flat, offset by a $40M FX tailwind. The lack of volume growth despite easy comps is a concern.
Reversing. Down 53% from $179M in 24Q4. The drop in profitability far exceeded the impact of flat sales, highlighting the operating leverage trap the company is currently in.
Guidance
Stable/Decelerating. The midpoint ($8.5B) implies a ~1.3% decline vs 2025. This suggests management does not expect a meaningful volume recovery or pricing power return in the near term.
Decelerating. Midpoint represents a ~17% decline vs 2025. Management explicitly lists a $130M negative impact from inventory reduction actions and a $100M incentive comp reset as headwinds.
Decelerating. Midpoint ($0.95) is down ~47% YoY from $1.80 in 2025. This reflects the lower EBITDA flowing through to the bottom line.
Accelerating. A massive jump from $169M in 2025, driven almost entirely by the ~$485M reduction in Capital Expenditures as major projects conclude.
Key Questions
Inventory Destocking Depth
You mention a $130M negative EBITDA impact in 2026 from inventory reduction actions. Is this a continuation of 2025 issues, and does this imply you are holding significantly more inventory than demand justifies? When does this headwind abate?
Normalized Margins
With 2026 guidance implying EBITDA margins dropping toward ~13-14%, what is the structural 'normalized' margin for this business post-Waco? The previous narrative was high-teens/low-20s; has that structurally changed?
Strategic Review Scope
Can you elaborate on the 'selective review of our portfolio'? Does this include potential divestitures of European assets or non-core converting facilities to accelerate deleveraging?
Leverage Comfort Zone
Leverage sits at 3.8x entering a year of declining EBITDA. Will all Free Cash Flow be directed to debt paydown, or is the dividend/buyback program still active at these levels?
Incentive Comp Reset
You flagged a $100M accrual for 'return to more normal incentive compensation' in 2026. Given the forecasted earnings decline, why is incentive comp increasing by such a magnitude?